| RS1064795104 |
EXOC6B
|
Health Risk |
Likely pathogenic |
— |
| RS1064795105 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064795106 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064795108 |
POLR1A
|
Health Risk |
Likely pathogenic |
Acrofacial dysostosis Cincinnati type, Acrofacial dysostosis Cincinnati type |
| RS1064795109 |
SGSH
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1064795110 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1064795112 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1064795113 |
SPTA1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1064795116 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064795117 |
WWOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 12, Developmental and epileptic encephalopathy |
| RS1064795118 |
TBL1XR1
|
Health Risk |
Pathogenic |
— |
| RS1064795119 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS1064795122 |
SLC6A3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795123 |
GARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1064795124 |
OTOGL
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064795125 |
PACS1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795127 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1064795130 |
COL4A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795136 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1064795139 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome |
| RS1064795140 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795142 |
KCNQ3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795143 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1064795147 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphatemic rickets |
| RS1064795148 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064795152 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1064795153 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1064795154 |
HK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with visual defects and brain anomalies, Neurodevelopmental disorder with visual defects and brain anomalies |
| RS1064795155 |
FN1
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia |
| RS1064795156 |
TSC2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795158 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795159 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795161 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064795164 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS1064795165 |
PURA
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation |
| RS1064795166 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795168 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064795172 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795175 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795180 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS1064795183 |
SLC9A6
|
Health Risk |
Pathogenic |
— |
| RS1064795184 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1064795199 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064795203 |
TP53
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1064795205 |
FGF23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064795208 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795212 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Abnormality of the nervous system |
| RS1064795213 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1064795215 |
CENPF
|
Health Risk |
Pathogenic/Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS1064795216 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1064795217 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795219 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1064795225 |
EZH2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795226 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS1064795227 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795228 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1064795229 |
FLNC
|
Health Risk |
Pathogenic |
Dilated Cardiomyopathy, Dominant |
| RS1064795230 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1064795231 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064795232 |
NFKB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795233 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Auditory neuropathy spectrum disorder, Auditory neuropathy spectrum disorder |
| RS1064795234 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1064795235 |
AP2S1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Familial hypocalciuric hypercalcemia 3 |
| RS1064795236 |
SNAP29
|
Health Risk |
Likely pathogenic |
CEDNIK syndrome, CEDNIK syndrome |
| RS1064795237 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1064795239 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795242 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS1064795244 |
RPS29
|
Health Risk |
Likely pathogenic |
— |
| RS1064795247 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795249 |
TUBB2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 5, Complex cortical dysplasia with other brain malformations 5 |
| RS1064795250 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS1064795251 |
VPS13B
|
Health Risk |
Likely pathogenic |
— |
| RS1064795254 |
ACADS
|
Health Risk |
Pathogenic |
— |
| RS1064795255 |
RPE65
|
Health Risk |
Likely pathogenic |
RPE65-related recessive retinopathy, Retinitis pigmentosa 20 |
| RS1064795256 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Endometrial carcinoma |
| RS1064795258 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795259 |
ZBTB18
|
Health Risk |
Likely pathogenic |
— |
| RS1064795261 |
RAD51D
|
Health Risk |
Likely pathogenic |
— |
| RS1064795262 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795263 |
EIF2B5
|
Health Risk |
Likely pathogenic |
— |
| RS1064795264 |
MSH2
|
Health Risk |
Pathogenic |
— |
| RS1064795267 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1064795270 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064795274 |
NLRC4
|
Health Risk |
Likely pathogenic |
— |
| RS1064795279 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1064795280 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS1064795281 |
AFG3L2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795282 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1064795283 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS1064795285 |
TSC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 1, Lymphangiomyomatosis |
| RS1064795286 |
BRCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795287 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795290 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1064795296 |
RB1
|
Health Risk |
Pathogenic |
— |
| RS1064795297 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064795301 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1064795303 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064795304 |
PIK3CA
|
Health Risk |
Likely pathogenic |
— |
| RS1064795305 |
DYRK1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795306 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |